Award: Abstract Award for Excellence in Adult Basic Science
Name: Giuliana V. Zarrella
Abstract Number: NCOG-48
Presentation Title: A prospective longitudinal neurocognitive outcome study in patients treated with CAR-T-cell therapy at 6 months
Presentation Date: Friday, November 18, 2022
Presentation Time: 9:50 AM – 10:00 AM ET

Award: Abstract Award for Excellence in Neuro-Imaging
Name: Maciej Harat
Abstract Number: NIMG-39
Presentation Title: Amino acid PET-MRI of high-grade glioma
Presentation Date: Friday, November 18, 2022
Presentation Time: 1:35 PM – 1:45 PM ET

Award: Abstract Award for Excellence in Survivorship
Name: Kelcie D. Willis
Abstract Number: QOLP-24
Presentation Title: Silver linings: The experience of posttraumtic growth in neuro-oncology caregivers
Presentation Date: Friday, November 18, 2022
Presentation Time: 1:45 PM – 1:50 PM ET

Award: Abstract Award for Excellence in Healthcare Equity
Name: Joshua A. Budhu
Abstract Number: DISP-14
Presentation Title: Defining interventions and metrics to improve diversity in CNS clinical trial participation: a SNO and RANO effort
Presentation Date: Friday, November 18, 2022
Presentation Time: 2:05 PM – 2:10 PM ET

Award: Abstract Award for Excellence in Adult Basic Science
Name: Takahide Nejo
Abstract Number: CNSC-19
Presentation Title: Glioma-induced neuronal remodeling promotes regional immunosuppression
Presentation Date: Friday, November 18, 2022
Presentation Time: 3:50 PM – 4:00 PM ET

Award: Abstract Award for Excellence in Clinical Trials
Name: David Peereboom, David Reardon
Abstract Number: CTIM-29
Presentation Title: Phase 2 study of a novel immunotherapy SL-701 in adults with recurrent GBM: Identification of treatment-induced CD8+CD107a+ CD57+ PD-1- memory T-cells that are associated with increased survival
Presentation Date: Friday, November 18, 2022
Presentation Time: 4:15 PM – 4:25 PM ET

Award: Abstract Award for Excellence in Clinical Trials
Name: Capucine Baldini
Abstract Number: CTIM-03
Presentation Title: Pembrolizumab monotherapy for microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) recurrent gliomas: Results from the multicohort phase 2 KEYNOTE-158 study
Presentation Date: Friday, November 18, 2022
Presentation Time: 5:05 PM – 5:15 PM ET

Award: Abstract Award for Excellence in Molecular Pathology
Name: Simona Migliozzi
Abstract Number: EPCO-03
Presentation Title: Pathway-based stratification of glioblastoma by multi-omics informs subtype-specific master kinases-phosphosite substrates
Presentation Date: Saturday, November 19, 2022
Presentation Time: 10:55 AM – 11:05 AM ET

Award: Abstract Award for Excellence in Adult Basic Science
Name: Martha A. Cady
Abstract Number: CSIG-36
Presentation Title: Notch3 drives meningioma tumorigenesis and resistance to radiotherapy
Presentation Date: Saturday, November 19, 2022
Presentation Time: 12:45 PM – 12:55 PM ET

Award: Abstract Award for Excellence in CNS Metastases Award
Name: Lu Sun
Abstract Number: TMIC-02
Presentation Title: Pre-surgical immune checkpoint blockade reshapes the immune landscape and spatial architecture of metastatic brain tumors
Presentation Date: Saturday, November 19, 2022
Presentation Time: 12:45 PM – 12:55 PM ET

Award: Andrew Parsa Young Investigator Award
Name: Julie Bennett
Abstract Number: EPID-25
Presentation Title: The clinical and molecular landscape of gliomas in adolescents and young adults
Presentation Date: Saturday, November 19, 2022
Presentation Time: 4:15 PM – 4:25 PM ET

Award: Abstract Award for Excellence in Radiation
Name: Justin Wang
Abstract Number: RBIO-06
Presentation Title: Clinical and molecular predictors of radiation responsiveness in meningiomas: a multicenter retrospective cohort study
Presentation Date: Saturday, November 19, 2022
Presentation Time: 4:25 PM – 4:35 PM ET

Award: Marit Mary Swenson Award for Pediatric DMG/DIPG
Name: Charles A. Day
Abstract Number: CCRG-02
Presentation Title: The diffuse midline glioma mutations, H3.3 K27M and G34R/V, inhibit mitotic phosphorylation of Serine 31, leading to tumor formation through increased chromosomal instability
Presentation Date: Saturday, November 19, 2022
Presentation Time: 4:35 PM – 4:45 PM ET

Award: Abstract Award for Excellence in CNS Rare Disease/Neurogenetic Tumor Syndromes
Name: Scott R. Plotkin
Abstract Number: CTNI-65
Presentation Title: INTUITT-NF2, an adaptive platform-basket trial for neurofibromatosis 2 patients with progressive tumors: interim results of the brigatinib treatment arm
Presentation Date: Saturday, November 19, 2022
Presentation Time: 5:05 PM – 5:15 PM ET

Award: Abstract Award for Excellence in Surgery
Name: Philipp Karschnia
Abstract Number: SURG-19
Presentation Title: Prognostic validation of a new classification system for extent of resection in glioblastoma: a report of the RANO resect group
Presentation Date:Saturday, November 19, 2022
Presentation Time: 5:05 PM – 5:15 PM ET

Award: Abstract Award for Excellence in Pediatric Basic Science
Name: Karen D. Wright
Abstract Number: CTNI-53
Presentation Title: PNOC014: Phase IB study results of DAY101(tovorafenib) for children with low-grade gliomas (LGGs) and other RAS/RAF/MEK/ERK pathway-activated tumors
Presentation Date: Saturday, November 19, 2022
Presentation Time: 5:15 PM – 5:20 PM ET

Electronic Poster Awards